Behavioral Evaluation of rotenone model of Parkinson’s disease in male Wistar rats | ||
| Sohag Medical Journal | ||
| Article 2, Volume 24, Issue 2, April 2020, Pages 8-14 PDF (224.75 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/smj.2020.21596.1089 | ||
| Authors | ||
| dina monir hegab* 1; Omyma Galal Ahmed2; Motamed Mahmoud3; Amany Abderahman Abdelhamid4 | ||
| 1Medical Physiology department, Sohag Faculty of Medicine, Sohag university | ||
| 2Department of physiology, Faculty of medicine, Assuit University, Assuit, Egypt | ||
| 3Department of Animal Behavior and Husbandry, Faculty of Veterinary Medicine, Sohag, University, Sohag, Egypt | ||
| 4physiology department, faculty of medicine, Sohag university | ||
| Abstract | ||
| Introduction: Parkinson’s disease (PD) is a prevalent neurodegenerative disorder in elderly people. The condition is associated with damage to the dopaminergic neurons in the substantia nigra pars compacta, a great decrement of dopamine neurotransmitter in the striatum, and a deficiency of tyrosine hydroxylase; the rate-determining enzyme during dopamine formation. In rats, rotenone has been administered to induce a syndrome that mimics the behavioral and pathophysiological finding of Parkinson's disease. Aim of the work: To evaluate the behavioral aspects of PD in rotenone-treated Wistar rats. Materials and Methods: Rotenone at 2 mg/kg was injected subcutaneously to male adult Wistar rats in the rotenone-treated group once a day for 4 weeks for induction of PD. Open Field test, object recognition test, Rota-rod test, footprint test and forced swim test were performed at the end of induction. Tyrosine hydroxylase levels in the brain were measured. Results: Our data showed deteriorated behavioral aspects after rotenone treatment, with a decrease in exploration and locomotion, impaired motor coordination, asymmetrical impaired gait, increased depressive-like behaviors, reduction in short-term memory and reduction in tyrosine hydroxylase levels. Conclusion: in this study, rotenone subcutaneously at a dose of 2 mg/kg daily for 4 weeks, in adult male Wistar rats, caused the appearance of the motor and the non-motor features of PD with a marked drop-off tyrosine hydroxylase levels in the striatum. | ||
| Keywords | ||
| Rotenone; Parkinson’s disease; Wistar rats | ||
|
Supplementary Files
|
||
|
Statistics Article View: 939 PDF Download: 1,538 |
||
